Filing Flows › Dentsply Sirona (XRAY) › Q3 2026 › vs Q3 2025
Dentsply Sirona (XRAY) Q3 2026 vs Q3 2025 (year over year)
Dentsply Sirona's revenue fell $68.0M (-8%) from $904M in Q3 2025 to $836M in Q3 2026.
Dentsply Sirona, Q3 2026: revenue $836M (-8% year over year), operating margin 4.4%, net loss $3.0M, operating cash flow $32.0M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Free cash flow margin | 0.0% | 4.4% | -4.4 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $836M | $904M | −$68.0M | -8% |
| Net loss | $3.0M | $428M | −$425M | -99% |
| Costs & expenses | $839M | $1.3B | −$493M | -37% |
| Operating costs | $799M | $1.1B | −$323M | -29% |
| Interest & other, net | $11.0M | $12.0M | −$1.0M | -8% |
| Income tax | $29.0M | $198M | −$169M | -85% |
| Cost of revenue | $393M | $463M | −$70.0M | -15% |
| Research & development | $42.0M | $37.0M | $5.0M | +14% |
| SG&A | $363M | $355M | $8.0M | +2% |
| Operating cash sources | $90.0M | $98.0M | −$8.0M | -8% |
| Depreciation & amortization | $82.0M | $92.0M | −$10.0M | -11% |
| Share-based compensation | $8.0M | $6.0M | $2.0M | +33% |
| Net loss absorbed | $3.0M | $428M | −$425M | -99% |
| Working capital & other | $55.0M | −$409M | $464M | — |
| Operating cash flow | $32.0M | $79.0M | −$47.0M | -59% |
| Free cash flow (OCF − capex) | $0 | $40.0M | −$40.0M | -100% |
| Capital expenditures | $32.0M | $39.0M | −$7.0M | -18% |
Questions
How much did Dentsply Sirona's revenue grow year over year in Q3 2026?
Dentsply Sirona's revenue fell $68.0M (-8%) from $904M in Q3 2025 to $836M in Q3 2026.